NCT03066947 - SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

November 22, 2018

Study Completion Date

November 22, 2018

Conditions

BreastcancerBreast Neoplasm

Interventions

BIOLOGICAL

SV-BR-1-GM

See above

DRUG

Cyclophosphamide

Low dose pre-treatment to reduce regulatory T cells

BIOLOGICAL

Interferon-alpha-2b

Low dose given in the vaccine site to boost the immune response

Trial Locations (5)

Thomas Jefferson University, Philadelphia

University of Miami/Sylvester at Plantation, Plantation

Cancer Center of Kansas (CCK), Wichita

St. Joseph Heritage Healthcare, Santa Rosa

Providence Regional Medical Center, Everett